Relationship between soluble thrombomodulin in patients with intermittent claudication and critical ischemia

Thrombosis Research

Volumn 117, Issue 3, 2006, Pages 271-277

  Nasser, M ^a,b   Wolosker, N ^a   Uint, L ^a   Rosoky, R A ^a   Lobato, M ^a   Wajngarten, M ^a   Puech Leao, P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b University of Sao Paulo Medical School ^*  (Brazil)

Author keywords

Atherosclerosis; Critical limb ischemia; Endothelium; Intermittent claudication; Thrombomodulin

Indexed keywords

BIOLOGICAL MARKER; THROMBOMODULIN;

ADULT; AGED; ARTERY DISEASE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOTHESIS; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PLASMA; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

AGED; ARTERIAL OCCLUSIVE DISEASES; ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; INTERMITTENT CLAUDICATION; ISCHEMIA; MALE; MIDDLE AGED; MODELS, STATISTICAL; REPRODUCIBILITY OF RESULTS; THROMBOMODULIN; TIME FACTORS;

EID: 29244476040     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.03.010     Document Type: Article

References (52)

1. D.P. Faxon, V. Fuster, P. Libby, J.A. Beckman, W.R. Hiatt, and R.W. Thompson Atherosclerotic vascular disease conference: writing group: III. Pathophysiology Circulation 109 21 2004 (Jun 1) 2617 2625
2. D.T. Price, and J. Loscalzo Cellular cules and atherogenesis Am J Med 107 1 1999 (Jul) 85 97
3. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 9 2002 (Mar 5) 1135 1143
4. A.D. Blann, and D.A. Taberner A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 90 2 1995 (Jun) 244 248
5. A. Hamsten The hemostatic system and coronary heart disease Thromb Res 70 1 1993 (Apr 1) 1 38
6. J.D. Pearson Vessel wall interactions regulating thrombosis Br Med Bull 50 4 1994 (Oct) 776 788
7. V. Salomaa, C. Matei, N. Aleksic, L. Sansores-Garcia, A.R. Folsom, and H. Juneja Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study Lancet 353 9166 1999 (May 22) 1729 1734
8. N.L. Esmon, W.G. Owen, and C.T. Esmon Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C J Biol Chem 257 2 1982 (Jan 25) 859 864
9. A.D. Blann, M. Seigneur, M. Steiner, M.R. Boisseau, and C.N. McCollum Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease Eur J Clin Invest 27 11 1997 (Nov) 916 921
10. K. Handa, M. Takao, J. Nomoto, K. Oku, K. Shirai, and K. Saku Evaluation of the coagulation and fibrinolytic systems in men with intermittent claudication Angiology 47 6 1996 (Jun) 543 548
11. C. Conri, M. Seigneur, J. Constans, P. Mercier, J.C. Baste, and P. Dufourcq Evidence of elevated soluble plasma thrombomodulin in atherosclerosis J Mal Vasc 18 2 1993 112 118
12. M.C. Boffa, and M. Karmochkine Thrombomodulin: an overview and potential implications in vascular disorders Lupus 7 Suppl 2 1998 S120 S125
13. C.T. Esmon Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface FASEB J 9 1995 946 955
14. M. Seigneur, P. Dufourcq, C. Conri, J. Constans, P. Mercie, and A. Pruvost Levels of plasma thrombomodulin are increased in atheromatous arterial disease Thromb Res 71 6 1993 (Sep 15) 423 431
15. A.D. Blann, A. Farrell, A. Picton, and C.N. McCollum Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease Thromb Res 97 4 2000 (Feb 15) 209 216
16. S. John, W. Drobnik, K. Lackner, and R.E. Schmieder Soluble thrombomodulin and endothelial dysfunction in early atherosclerosis Lancet 354 9190 1999 (Nov 6) 1647
17. V. Salomaa, C. Matei, N. Aleksic, L. Sansores-Garcia, A.R. Folsom, and H. Juneja Cross-sectional association of soluble thrombomodulin with mild peripheral artery disease; the ARIC study. Atherosclerosis Risk in Communities Atherosclerosis 157 2 2001 (Aug) 309 314
18. K. Peter, P. Nawroth, C. Conradt, T. Nordt, T. Weiss, and M. Boehme Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin Arterioscler Thromb Vasc Biol 17 3 1997 (Mar) 505 512
19. T. Sernau, C. Wilhelm, U. Seyfert, S. Gabath, M. Henkels, and J. Amiral Thrombomodulin is a marker of microvascular, but not for macrovascular endothelial cell damage Vasa 24 4 1995 347 353
20. TASC Transatlantic Inter-Society Consensus-Management of Peripheral Arterial Disease (PAD) J Vasc Surg 1 2 2000 (Jan 31)
21. W.R. Hiatt The evaluation of exercise performance in patients with peripheral vascular disease J Cardiopulm Rehabil 12 4 1998 525 535
22. N. Wolosker, L. Nakano, R.A. Rosoky, and P. Puech-Leao Evaluation of walking capacity over time in 500 patients with intermittent claudication who underwent clinical treatment Arch Intern Med 163 19 2003 (Oct 27) 2296 2300
23. S.T. Yao Haemodynamic studies in peripheral arterial disease Br J Surg 57 10 1970 (Oct) 761 766
24. C.J. Hemmer, A. Bierhaus, J. von Riedesel, S. Gabat, B. Liliensiek, and P. Pitronik Elevated thrombomodulin plasma levels as a result of endothelial involvement in Plasmodium falciparum malaria Thromb Haemost 72 3 1994 (Sep) 457 464
25. S. Iwabuchi, Y. Yoshida, A. Kamogawa, N. Moriyama, M. Takatori, and A. Mizuguchi Plasma thrombomodulin in liver diseases Gastroenterol Jpn 25 5 1990 (Oct) 661
26. G.F. de Larranaga, A.R. Bocassi, L.M. Puga, B.S. Alonso, and J.A. Benetucci Endothelial markers and HIV infection in the era of highly active antiretroviral treatment Thromb Res 110 2-3 2003 (May 1) 93 98
27. A.D. Blann, C. Devine, J. Amiral, and C.N. McCollum Soluble adhesion molecules, endothelial markers and atherosclerosis risk factors in abdominal aortic aneurysm: a comparison with claudicants and healthy controls Blood Coagul Fibrinolysis 9 6 1998 (Sep) 479 484
28. S. Takano, S. Kimura, S. Ohdama, and N. Aoki Plasma thrombomodulin in health and diseases Blood 76 10 1990 (Nov 15) 2024 2029
29. E. Morishita, M. Saito, H. Asakura, H. Jokaji, C. Uotani, and I. Kumabashiri Increased levels of plasma thrombomodulin in chronic myelogenous leukemia Am J Hematol 39 3 1992 (Mar) 183 187
30. H. Mihara, A. Murai, K. Handa, K. Saku, K. Shirai, and K. Tanaka Thrombomodulin levels in patients with coronary artery disease Artery 22 6 1997 293 308
31. D.A. Tsakiris, M. Tschopl, K. Jager, W.E. Haefeli, F. Wolf, and G.A. Marbet Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease Atherosclerosis 142 1 1999 (Jan) 193 200
32. C.T. Esmon, and W.G. Owen Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C Proc Natl Acad Sci U S A 78 4 1981 (Apr) 2249 2252
33. R.M. Loreth, Ch. Seus, H.H. Berger, and F.W. Albert Plasma thrombomodulin concentrations in healthy persons depends on age and sex Ann Hematol 74 suppl II 1997 A89
34. H. Weiler, and B.H. Isermann Thrombomodulin J Thromb Haemost 1 7 2003 (Jul) 1515 1524
35. K.K. Wu, N. Aleksic, C.M. Ballantyne, C. Ahn, H. Juneja, and E. Boerwinkle Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease Circulation 107 13 2003 (Apr 8) 1729 1732
36. F. Califano, T. Giovanniello, P. Pantone, E. Campana, C. Parlapiano, and F. Alegiani Clinical importance of thrombomodulin serum levels Eur Rev Med Pharmacol Sci 4 3 2000 (May-Jun) 59 66
37. J. Shi, J. Wang, H. Zheng, W. Ling, J. Joseph, and D. Li Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation Blood Coagul Fibrinolysis 14 6 2003 (Sep) 575 585
38. M. Rigla, J. Fontcuberta, J. Mateo, A. Caixas, J.M. Pou, and A. de Leiva Physical training decreases plasma thrombomodulin in type I and type II diabetic patients Diabetologia 44 6 2001 (Jun) 693 699
39. Y. Terada, Y. Eguchi, S. Nosaka, T. Toba, T. Nakamura, and Y. Shimizu Capillary endothelial thrombomodulin expression and fibrin deposition in rats with continuous and bolus lipopolysaccharide administration Lab Invest 83 8 2003 (Aug) 1165 1173
40. H. Ishii, K. Kizaki, S. Horie, and M. Kazama Oxidized low density lipoprotein reduces thrombomodulin transcription in cultured human endothelial cells through degradation of the lipoprotein in lysosomes J Biol Chem 271 14 1996 (Apr 5) 8458 8465
41. E. Nomura, T. Kohriyama, K. Kozuka, H. Kajikawa, S. Nakamura, and M. Matsumoto Significance of serum soluble thrombomodulin level in acute cerebral infarction Eur J Neurol 11 5 2004 (May) 329 334
42. Y.H. Li, J.H. Chen, H.L. Wu, G.Y. Shi, H.C. Huang, and T.H. Chao G-33A mutation in the promoter region of thrombomodulin gene and its association with coronary artery disease and plasma soluble thrombomodulin levels Am J Cardiol 85 1 2000 (Jan 1) 8 12
43. Y.H. Li, C.H. Chen, P.S. Yeh, H.J. Lin, B.I. Chang, and J.C. Lin Functional mutation in the promoter region of thrombomodulin gene in relation to carotid atherosclerosis Atherosclerosis 154 3 2001 (Feb 15) 713 719
44. J.L. Sperry, C.B. Deming, C. Bian, P.L. Walinsky, D.A. Kass, and F.D. Kolodgie Wall tension is a potent negative regulator of in vivo thrombomodulin expression Circ Res 92 1 2003 (Jan 10) 41 47
45. P.E. Morange, C. Simon, M.C. Alessi, G. Luc, D. Arveiler, and J. Ferrieres Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study Circulation 109 11 2004 (Mar 23) 1343 1348
46. Z.G. Laszik, X.J. Zhou, G.L. Ferrell, F.G. Silva, and C.T. Esmon Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis Am J Pathol 159 3 2001 (Sep) 797 802
47. P.A. Merlini, M.L. Rossi, E.M. Faioni, F. Franchi, E. Bramucci, and S. Lucreziotti Expression of endothelial protein C receptor and thrombomodulin in human coronary atherosclerotic plaques Ital Heart J 5 1 2004 (Jan) 42 47
48. A.M. Healy, W.W. Hancock, P.D. Christie, H.B. Rayburn, and R.D. Rosenberg Intravascular coagulation activation in a murine model of thrombomodulin deficiency: effects of lesion size, age, and hypoxia on fibrin deposition Blood 92 11 1998 (Dec 1) 4188 4197
49. L. Petit, F.V. van Oort, G. Le Gal, L.I. Mennen, M. Alhenc-Gelas, and P.J. Touboul Association of postmenopausal hormone replacement therapy with carotid atherosclerosis and soluble thrombomodulin: the vascular aging (EVA) study. Etude du Vieillissement Arteriel Thromb Res 105 4 2002 (Feb 15) 291 297
50. T. Nagasaki, M. Inaba, Y. Henmi, Y. Kumeda, M. Ueda, and H. Tahara Change in von Willebrand factor and carotid intima-media thickness in hypothyroid patients with normal thyroid function after levothyroxine replacement therapy Eur J Endocrinol 150 2 2004 (Feb) 125 131
51. M.W. Boehme, P. Galle, and W. Stremmel Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals Immunology 107 3 2002 (Nov) 340 349
52. G. Kunz, A.K. Ohlin, A. Adami, B. Zoller, P. Svensson, and D.A. Lane Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function Blood 99 10 2002 (May 15) 3646 3653